Thrombolytic Therapy: Clinical Trials

16 trials of Thrombolytic Therapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 5 unknown, 2 recruiting, 1 not yet recruiting. 7 Not applicable, 5 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable7Unknown 3, Completed 2, Not yet recruiting 1, Recruiting 1
Phase 35Completed 3, Recruiting 1, Unknown 1
Phase 41Completed 1

Follow Thrombolytic Therapy: new trials by email Literature Review of Thrombolytic Therapy trials Research Report on Thrombolytic Therapy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Role of Medical Thoracoscopy in Pleural Infection (PROMPT Trial)
medical thoracoscopy, Standard of Care - Pleural Infection, Pleural Infections
Not applicableNot yet recruitingUniversità Politecnica delle Marche1702026-11-012026-04-24
Thrombolysis in Factor Xa-inhibitors Trial
thrombolysis therapy - Stroke, Stroke (in Patients With Atrial Fibrillation)
Phase 3RecruitingGuri Hagberg3002025-03-142026-09-23
'Thrombectomy in High-Risk Pulmonary Embolism - Device Versus Thrombolysis Netherlands': TORPEDO-NL
Catheter-directed thrombectomy (CDT), thrombolysis therapy - Pulmonary Embolism Acute
Not applicableRecruitingLeiden University Medical Center1112025-02-012025-02-19
Using End-Tidal CO₂ to Help Diagnose and Monitor Pulmonary Embolism
thrombolytic therapy - Pulmonary Embolism Acute
CompletedAtaturk University1202025-02-012025-12-22
Relation of Laboratory Indices to Left Ventricular Thrombus Formation in Patients With Acute Anterior ST Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention or Thrombolytic Therapy
Primary percutaneous coronary intervention or thrombolytic therapy - Left Ventricular Thrombus
UnknownAssiut University4002024-01-012023-12-01
Effect of Thrombolysis on 30-day Mortality in Intermediate High Risk Pulmonary Patients With Low Bleeding Risk
Thrombolytic therapy for the study group in the form of streptokinase or recombinant tissue plasminogen activator, Unfractionated Heparin IV - Pulmonary Embolism Subacute Massive, Thrombolytic Therapy
Not applicableCompletedAin Shams University1002023-07-012026-01-29
A Prospective Evaluation of Clinical Impact of Physiology Versus Optical Coherence Tomography Guided PCI in STEMI Patients Without Undergoing Primary PCI
angiography, Thrombus suction, Fibrinolytic therapy - ST Elevation Myocardial Infarction
Not applicableUnknownCCRF Inc., Beijing, China3002021-07-312021-08-09
Treatment of Complicated Parapneumonic Effusion With Fibrinolytic Therapy Versus VATs Decortication
VATS Decortication, Fibrinolytic Therapy - Parapneumonic Effusion, Empyema, Pleural
Not applicableCompletedDenver Health and Hospital Authority102018-07-262022-01-27
Surgery Versus Fibrinolytic Therapy for Left-sided Prosthetic Heart Valve Thrombosis
Emergency surgery, Fibrinolytic therapy - Left-sided Prosthetic Heart Valve Thrombosis
Phase 3UnknownAll India Institute of Medical Sciences1152017-04-012017-03-10
Thrombolytic Therapy Versus Surgery for Obstructive Prosthetic Valve Thrombosis
Thrombolytic Therapy, Surgery - Obstructive Thrombus
Not applicableUnknownKartal Kosuyolu Yuksek Ihtisas Education and Research Hospital1002014-01-012014-09-18
Comparison of Thrombgolytic and Anticoagulation Therapy in Submassive Pulmonary Embolism
Actilyse (Thrombolytic therapy), Heparine (Standard anticoagulation therapy) - Pulmonary Embolism
Phase 4CompletedUniversity Hospital Ostrava1002011-03-012018-03-19
Stroke Research Consortium in Northern Bavaria (STAMINA)
thrombolysis therapy, endovascular therapy, decompressive surgery - Ischemic Stroke
CompletedUniversity of Erlangen-Nürnberg Medical School37692006-01-012022-08-02
A Study Comparing a New Dosing Regimen of Clot-dissolving Drug for Mechanical Heart Valves Which Show Clots
Streptokinase - Prosthetic Valve Thrombosis
Phase 3CompletedAll India Institute of Medical Sciences1202004-11-012013-10-24
Female Sex is an Independent Predictor of Death and Bleeding Among Fibrinolytic Treated Patients With AMI
fibrinolytic therapy or combination reduced fibrinolytic therapy - Myocardial Infarction
Phase 3CompletedNYU Langone Health2001-06-012012-10-04
Shock Trial: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.
angioplasty, transluminal, percutaneous coronary, coronary artery bypass, thrombolytic therapy - Cardiovascular Diseases, Coronary Disease
Phase 3CompletedCarelon Research1994-09-012014-03-04
Senior PAMI: Primary Angioplasty Versus Thrombolytic Therapy for Acute Myocardial Infarction in the Elderly
Thrombolytic therapy, Percutaneous coronary intervention (PCI) - Myocardial Infarction
Not applicableUnknownPAMI Coordinating Center5302005-12-13

Conditions studied

Myocardial Infarction (3)  ·  Cardiovascular Diseases (2)  ·  Ischemic Stroke (2)  ·  Stroke (2)  ·  Brain Diseases (1)  ·  Brain Ischemia (1)  ·  Central Nervous System Diseases (1)  ·  Cerebral Infarction (1)  ·  Cerebrovascular Disorders (1)  ·  Coronary Disease (1)  ·  Empyema, Pleural (1)  ·  Heart Diseases (1)  ·  Hemostatic Disorders (1)  ·  Inflammation (1)  ·  Intracranial Hemorrhages (1)

Sponsors

All India Institute of Medical Sciences (2)  ·  Ain Shams University (1)  ·  Assiut University (1)  ·  Ataturk University (1)  ·  CCRF Inc., Beijing, China (1)  ·  Carelon Research (1)  ·  Denver Health and Hospital Authority (1)  ·  Guri Hagberg (1)  ·  Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital (1)  ·  Leiden University Medical Center (1)  ·  NYU Langone Health (1)  ·  PAMI Coordinating Center (1)  ·  University Hospital Ostrava (1)  ·  University of Erlangen-Nürnberg Medical School (1)  ·  Università Politecnica delle Marche (1)

Countries

Turkey (Türkiye) (2)  ·  United States (2)  ·  Czechia (1)  ·  Denmark (1)  ·  Egypt (1)  ·  Germany (1)  ·  India (1)  ·  Netherlands (1)  ·  Norway (1)  ·  Sweden (1)

Top investigators

F. A. Klok, Prof. MD. PhD. (1)  ·  Felix Zijlstra, M.D. (1)  ·  Fredric Pieracci, MD, MPH (1)  ·  Ganesan Karthikeyan, MD, DM (1)  ·  Ganesan Karthikeyan, MD, DM, MSc (1)  ·  Harmony Reynolds (1)  ·  Lynn Sleeper (1)  ·  Radovan Stancik, MD (1)  ·  Stefan Schwab (1)  ·  Tobias Engelhorn (1)

Results publications

PMID 16757723, PMID 17954798, PMID 19738134, PMID 20826251, PMID 21416132, PMID 21830966, PMID 22779430, PMID 32421353, PMID 37553157, PMID 38710463, PMID 39049127, PMID 39182487, PMID 39827129, PMID 41027123, PMID 41243095

NIH funding

2023 (1), R01HL049970 (1)